Patents by Inventor Peter Kulsa

Peter Kulsa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4250174
    Abstract: Imidazo pyridines with a carbamate group in the 2-position and a phenylthio, or phenylsulfinyl group in the 6-position are disclosed which also are substituted at the 3-position. The 3-position substituents may be halogen, substituted aminomethyl, acyl, and the like. The compounds are active anthelmintic agents. Compositions and methods for the use of such compounds against helmintic infections are also disclosed.
    Type: Grant
    Filed: May 2, 1979
    Date of Patent: February 10, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Richard J. Bochis, Peter Kulsa, Richard L. Tolman
  • Patent number: 4237300
    Abstract: Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.
    Type: Grant
    Filed: November 9, 1979
    Date of Patent: December 2, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Richard J. Bochis, Peter Kulsa
  • Patent number: 4212880
    Abstract: Symmetrically substituted pyromellic diimides are disclosed wherein the compounds are substituted with a variety of substituent groups. The symmetrically substituted compounds are useful for administration to ruminant animals to increase feed efficiency, shift volatile fatty acid production in the ruminant from acetate with an increase in the more energetically efficient propionate and butyrate and to suppress methane formation in the rumen. Compositions and methods of treatment utilizing said compounds as the active ingredient thereof are also disclosed.
    Type: Grant
    Filed: October 23, 1978
    Date of Patent: July 15, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Michael H. Fisher, Peter Kulsa, Bruce O. Linn
  • Patent number: 4201861
    Abstract: Derivatives of C-076, a series of macrolides, are described in which the substituents are acyl groups. The acyl substituents may be aromatic of non-aromatic. The acyl derivatives are prepared by various procedures depending upon the particular C-076 compound being substituted. The compounds thus produced have profound anthelmintic, insecticidal, ectoparasiticidal and acaracidal activity and compositions for such uses are also disclosed.
    Type: Grant
    Filed: April 17, 1978
    Date of Patent: May 6, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Helmut H. Mrozik, Michael H. Fisher, Peter Kulsa
  • Patent number: 4177274
    Abstract: Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.
    Type: Grant
    Filed: June 5, 1978
    Date of Patent: December 4, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Richard J. Bochis, Peter Kulsa
  • Patent number: 4144345
    Abstract: Dihydroxybenzisoxazolin-3-yl-substituted-1-methyl-5-nitroimidazoles having the hydroxy- groups on adjacent 4,5-; 5,6- or 6,7-positions of the isoxazolin group. These compounds have antibacterial and antiprotozoal activity in humans and animals. They are particularly active against trypanosomiasis and trichomoniasis.
    Type: Grant
    Filed: January 6, 1978
    Date of Patent: March 13, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Helmut H. Mrozik, Peter Kulsa
  • Patent number: 4130661
    Abstract: Novel substituted benzoylacrylanilides are prepared by reacting a substituted benzoylacrylic acid with a substituted aniline in the presence of a coupling agent. These acrylanilides have significant anticoccidial activity.
    Type: Grant
    Filed: June 30, 1977
    Date of Patent: December 19, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Peter Kulsa, Dale R. Hoff, Helmut H. Mrozik
  • Patent number: 4096264
    Abstract: Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.
    Type: Grant
    Filed: August 26, 1976
    Date of Patent: June 20, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Richard J. Bochis, Peter Kulsa
  • Patent number: 4080340
    Abstract: Novel substituted nitroimidazoles are provided, for example, 2-(4,5-substituted-isoxazol-3-yl)-1-substituted-5-nitroimidazole; 2-(4,5-disubstituted-.DELTA..sup.2 -isoxazolin-3-yl)-1-substituted-5-nitroimidazole; or 2-(4,5-disubstituted-2-loweralkyl-isoxazolidin-3-yl)-1-substituted-5-nitro imidazole. These compounds have antibacterial and antiprotozoal activity especially against human and animal trypanosomiasis and trichomoniasis.
    Type: Grant
    Filed: September 15, 1976
    Date of Patent: March 21, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Peter Kulsa, Clarence S. Rooney
  • Patent number: 4010176
    Abstract: Novel substituted nitroimidazoles are provided, for example, 2-(4,5-substituted-isoxazol-3-yl)-1-substituted-5-nitroimidazole; 2-(4,5-disubstituted-.DELTA..sup.2 -isoxazolin-3-yl)-1-substituted-5-nitroimidazole; or 2-(4,5-disubstituted-2-loweralkyl-isoxazolidin-3-yl)-1-substituted-5-nitro imidazole. These compounds have antibacterial and antiprotozoal activity, especially against human and animal trypanosomiasis and trichomoniasis.
    Type: Grant
    Filed: July 30, 1975
    Date of Patent: March 1, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Peter Kulsa, Clarence S. Rooney
  • Patent number: 3968228
    Abstract: 4-Nitro-5-cyanoimidazoles substituted with a 1-loweralkyl group and variously substituted at the 2-position are useful as antiparasitic agents particularly as coccidiostats. The 4-nitro-5-cyanoimidazole coccidiostats are included in compositions useful for administration to poultry as treatment for coccidiosis.
    Type: Grant
    Filed: February 10, 1975
    Date of Patent: July 6, 1976
    Assignee: Merck & Co., Inc.
    Inventors: Dale R. Hoff, Peter Kulsa, Helmut H. Mrozik, Edward F. Rogers